comparemela.com

Latest Breaking News On - Christoph gretler - Page 1 : comparemela.com

FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Credit Suisse reaffirms its Neutral rating

Analyst Christoph Gretler from Credit Suisse research gives the stock a Neutral rating. Previously set at EUR 42, the target price has been raised to EUR 45.

Fresenius Medical Care AG & Co KGaA (NYSE:FMS) Q2 2023 Earnings Call Transcript

FRESENIUS SE : Gets a Neutral rating from Credit Suisse

In a research note published by Christoph Gretler, Credit Suisse gives a Neutral rating to the stock. The target price is increased from EUR 26 to EUR 27.

FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Credit Suisse remains Neutral

In his latest research note, analyst Christoph Gretler confirms his recommendation. The broker Credit Suisse is keeping its Neutral rating. The target price has been revised upwards and is now set at.

GERRESHEIMER AG : Gets a Buy rating from Credit Suisse

Already positive, the research from Credit Suisse and its analyst Christoph Gretler still consider the stock as a Buy opportunity. Previously set at EUR 110, the target price has been raised to EUR.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.